Comparison of outcomes in patients with or without ARC-HBR criteria undergoing PCI with polymer-free biolimus coated stents: The BioFreedom France study.
Philippe GarotPhilippe BrunelAlain DibieJean-François MorelleMohamed AbdellaouiRaphy LevyDidier CarriéBernard KarsentyChristophe RobinJacques BerlandSamuel CoptSara Sadozai SlamaKeith OldroydMarie-Claude MoriceJanusz Lipieckinull nullPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)
In this multicenter all-comers study, HBR patients treated with a polymer-free biolimus coated stent had, compared to non-HBR patients, an increased risk of cardiac death and MI, and despite a shorter duration of DAPT, continued to have higher rates of BARC 3-5 bleeding.
Keyphrases
- end stage renal disease
- ejection fraction
- acute coronary syndrome
- atrial fibrillation
- type diabetes
- acute myocardial infarction
- antiplatelet therapy
- prognostic factors
- coronary artery disease
- cross sectional
- peritoneal dialysis
- adipose tissue
- metabolic syndrome
- insulin resistance
- skeletal muscle
- weight loss
- st segment elevation myocardial infarction
- double blind
- coronary artery bypass